Kaushik Mandal

• Working on prelaunch core brand strategy for Ixfenro (Statin & Dyslipidaemia portfolios) for European Market • Prepared brand communication strategy for Rozor, Lipanthyl (Statin & Dyslipidaemia portfolios) including Europe and UK markets. • Prepared patient funnel and patient journey for Emerging market for diabetes patient. • Worked with US Medical Director (US Medical Affairs) in medical launch strategy preparation for Aspart Insulin (Diabetes) & Bevacizumab (Oncology) for US market.

• Existing relationship and network in Nephrology & Endocrinology KOL community globally including Europe. • Conducted market research and patient evaluation survey for two innovative renal products in India markets. • Prepared patient journey and patient funnel for renal and diabetes therapeutic areas for India markets • Received a positive recommendation towards approval from the local regulatory body for HIF-PHI class (Renal) both dialysis and non-dialysis indication

• Implemented vaccination protocol in 8 key institutes in India. • Received two positive recommendation letters from key institutes for the Pfizer vaccine. • Launched vaccine (extended indication) and anticoagulant molecule in the Indian market.

• Successfully identified fraud claims through investigation • Training for sales and commercial teams, maintaining company standard policy and governance.